New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Mexico City [Mexico], October 12 (ANI/Xinhua): Mexico has paid an advance of 159.8 million US dollars to guarantee the purchase of a successful vaccine against the novel coronavirus (COVID-19) through the COVAX initiative, the Mexican foreign ministry reported on Saturday.
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
Lucknow (Uttar Pradesh) [India], September 25 (ANI): The Uttar Pradesh government on Thursday announced that phase-3 trial of the coronavirus vaccine 'COVAXIN' will start in Lucknow and Gorakhpur from October.
Chandigarh (Punjab) [India], September 22 (ANI): Three Government Medical Colleges in Punjab will participate in the phase 3 trials of the COVAXIN being tested by Bharat Biotech Ltd in collaboration with the Indian Council of Medical Research (ICMR) against COVID-19, said a statement from th
New Delhi [India], September 18 (ANI): There is a possibility of situation created by COVID-19 returning to normal by the middle of next year even if a vaccine is not developed by then, Dr Sanjay Rai, Professor in Community Medicine Department at AIIMS here, has said.
Washington [US], September 2 (ANI): The United States has said it will not join a global effort led by the World Health Organisation (WHO) to develop, manufacture and distribute a vaccine to cure coronavirus.
Bhubaneswar (Odisha) [India], July 28 (ANI): The human trial of India's first indigenous vaccine candidate 'Covaxin' began at the Institute of Medical Sciences and SUM Hospital in Bhubaneswar on Monday.
Rohtak (Haryana) [India], July 26 (ANI): The first part of phase-1 of Covaxin human trial completed on Saturday at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr Savita Verma, principal investigator of the vaccine trial team.
New Delhi [India], July 24 (ANI): The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country's first indigenous vaccine candidate `Covaxin' to a 30-year-old man as part of efforts to combat COVID-19.
New Delhi [India], July 22 (ANI): Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine.
Panaji (Goa) [India], July 21 (ANI): Goa Chief Minister Pramod Sawant has said that the human trials of coronavirus vaccine have begun at the state's Redkar Hospital and congratulated the team behind it.